These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23647774)

  • 1. Preclinical radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H.
    Bretin F; Warnock G; Bahri MA; Aerts J; Mestdagh N; Buchanan T; Valade A; Mievis F; Giacomelli F; Lemaire C; Luxen A; Salmon E; Seret A; Plenevaux A
    EJNMMI Res; 2013 May; 3(1):35. PubMed ID: 23647774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
    Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
    Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human adult and adolescent biodistribution and dosimetry of the synaptic vesicle glycoprotein 2A radioligand
    Bini J; Holden D; Fontaine K; Mulnix T; Lu Y; Matuskey D; Ropchan J; Nabulsi N; Huang Y; Carson RE
    EJNMMI Res; 2020 Jul; 10(1):83. PubMed ID: 32666239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation Dosimetry of a Novel Adenosine A
    Zhou X; Elsinga PH; Khanapur S; Dierckx RA; de Vries EF; de Jong JR
    Mol Imaging Biol; 2017 Apr; 19(2):289-297. PubMed ID: 27539309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 18F-UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain.
    Warnock GI; Aerts J; Bahri MA; Bretin F; Lemaire C; Giacomelli F; Mievis F; Mestdagh N; Buchanan T; Valade A; Mercier J; Wood M; Gillard M; Seret A; Luxen A; Salmon E; Plenevaux A
    J Nucl Med; 2014 Aug; 55(8):1336-41. PubMed ID: 24935992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.
    Constantinescu CC; Tresse C; Zheng M; Gouasmat A; Carroll VM; Mistico L; Alagille D; Sandiego CM; Papin C; Marek K; Seibyl JP; Tamagnan GD; Barret O
    Mol Imaging Biol; 2019 Jun; 21(3):509-518. PubMed ID: 30084043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.
    Doss M; Kolb HC; Zhang JJ; Bélanger MJ; Stubbs JB; Stabin MG; Hostetler ED; Alpaugh RK; von Mehren M; Walsh JC; Haka M; Mocharla VP; Yu JQ
    J Nucl Med; 2012 May; 53(5):787-95. PubMed ID: 22499613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human biodistribution and dosimetry of [
    Cawthorne C; Maguire P; Mercier J; Sciberras D; Serdons K; Bormans G; de Hoon J; Van Laere K; Koole M
    EJNMMI Phys; 2021 Apr; 8(1):37. PubMed ID: 33891195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry.
    Smolarz K; Krause BJ; Graner FP; Wagner FM; Hultsch C; Bacher-Stier C; Sparks RB; Ramsay S; Fels LM; Dinkelborg LM; Schwaiger M
    J Nucl Med; 2013 Jun; 54(6):861-6. PubMed ID: 23568366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.
    Lee CL; Wahnishe H; Sayre GA; Cho HM; Kim HJ; Hernandez-Pampaloni M; Hawkins RA; Dannoon SF; VanBrocklin HF; Itsara M; Weiss WA; Yang X; Haas-Kogan DA; Matthay KK; Seo Y
    Med Phys; 2010 Sep; 37(9):4861-7. PubMed ID: 20964203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
    Nabulsi NB; Mercier J; Holden D; Carré S; Najafzadeh S; Vandergeten MC; Lin SF; Deo A; Price N; Wood M; Lara-Jaime T; Montel F; Laruelle M; Carson RE; Hannestad J; Huang Y
    J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body biodistribution kinetics, metabolism, and radiation dosimetry estimates of 18F-PEG6-IPQA in nonhuman primates.
    Tian M; Ogawa K; Wendt R; Mukhopadhyay U; Balatoni J; Fukumitsu N; Uthamanthil R; Borne A; Brammer D; Jackson J; Mawlawi O; Yang B; Alauddin MM; Gelovani JG
    J Nucl Med; 2011 Jun; 52(6):934-41. PubMed ID: 21571803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice.
    Constantinescu CC; Sevrioukov E; Garcia A; Pan ML; Mukherjee J
    Mol Imaging Biol; 2013 Apr; 15(2):222-9. PubMed ID: 22833323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer.
    Zanzonico PB; Finn R; Pentlow KS; Erdi Y; Beattie B; Akhurst T; Squire O; Morris M; Scher H; McCarthy T; Welch M; Larson SM; Humm JL
    J Nucl Med; 2004 Nov; 45(11):1966-71. PubMed ID: 15534070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and Radiation Dosimetry for the Tau Tracer
    Hsiao IT; Lin KJ; Huang KL; Huang CC; Chen HS; Wey SP; Yen TC; Okamura N; Hsu JL
    J Nucl Med; 2017 Sep; 58(9):1498-1503. PubMed ID: 28336780
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiation dose estimates for [18F]5-fluorouracil derived from PET-based and tissue-based methods in rats.
    Kesner AL; Hsueh WA; Czernin J; Padgett H; Phelps ME; Silverman DH
    Mol Imaging Biol; 2008; 10(6):341-8. PubMed ID: 18679756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172.
    O'Keefe GJ; Saunder TH; Ng S; Ackerman U; Tochon-Danguy HJ; Chan JG; Gong S; Dyrks T; Lindemann S; Holl G; Dinkelborg L; Villemagne V; Rowe CC
    J Nucl Med; 2009 Feb; 50(2):309-15. PubMed ID: 19164222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ).
    Laymon CM; Narendran R; Mason NS; Carney JP; Lopresti BJ; Mathis CA; Mountz JM; Sashin D; Frankle WG
    Mol Imaging Biol; 2012 Feb; 14(1):115-22. PubMed ID: 21365327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [
    Doot RK; Young AJ; Daube-Witherspoon ME; Alexoff D; Labban KJ; Lee H; Wu Z; Zha Z; Choi SR; Ploessl KH; Schubert EK; Lee H; Zhu L; Reddin JS; Karp JS; Kung H; Pryma DA
    Nucl Med Biol; 2020; 86-87():1-8. PubMed ID: 32361089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates.
    Quinn B; Dauer Z; Pandit-Taskar N; Schoder H; Dauer LT
    BMC Med Imaging; 2016 Jun; 16(1):41. PubMed ID: 27317478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.